Invitation: From July 19 to July 21, 2023, Haibu invites you to Beijing, China for the "Frontier Technology Summit on Drug Formulation".
Classification:
Recent Events
Release time:
2023-09-18
- Conference Time:July 20-21, 2023
- Conference Location:Crowne Plaza Beijing Lido, China
- Haibu Booth:No. 5
- Speech Topic:"Focus Points in the Pharmaceutical Development of Pediatric Transdermal Preparations"
- Speech Time:间: July 21, 2023, 11:20-11:50
Speaker:Dr. Diwei
, Deputy General Manager of Beijing Haibu Pharmaceutical;, PhD from the Academy of Military Medical Sciences of the PLA.
- , previously worked at the National Medical Products Administration, participated in the review of multiple innovative drugs and the drafting of several guidelines;评及多个指导原则的撰写工作；
- , has engaged in R&D and management work for various innovative and generic drugs, obtaining multiple patent authorizations and registration approvals;得多项专利授权和注册批件；
- , currently serves as Deputy General Manager of Beijing Haibu Pharmaceutical Technology Co., Ltd., mainly responsible for the R&D management of innovative drugs and improved new drugs, as well as intellectual property and clinical registration application management.责创新药、改良型新药的研发管理工作，以及知识产权和临床注册申报管理等工作。
(Beijing Haibu Pharmaceutical Technology Co., Ltd. (referred to as "Haibu Pharmaceutical") was established in 2005 and is a high-tech enterprise with "chemical drug R&D" as its core capability. It has a research and development center in Beijing, an API and formulation pilot verification center, and a GMP industrial production base, mainly engaged in CRO services for APIs and formulations, MAH joint licensing, API-related applications, and commercial supply of pharmaceutical intermediates.)
在化学原料药、口服固体、液体制剂、无菌注射剂、外用制剂等多种剂型的研发转产、注册申报等方面经验丰富。研发产品涉及抗肿瘤、抗抑郁、抗癫痫、抗焦虑、心脑血管、消化系统、呼吸系统等多个适应症领域。
(Haibu Pharmaceutical has rich experience in the R&D transfer production, registration application, etc., of various dosage forms such as chemical APIs, oral solids, liquid preparations, sterile injections, external preparations. The R&D products cover multiple therapeutic areas including anti-tumor, anti-depression, anti-epilepsy, anti-anxiety, cardiovascular diseases, digestive system diseases, respiratory system diseases.)
Beijing Hope Pharmaceutical Co., Ltd.
